Indeed, Sema3f inhibits angiogenesis [68], metastasis and motility of primary tumor cells, and decreased expression of Sema3f is correlated with advanced disease stages and more aggressive tumors in human NSCLC [69], indicating its important role in lung carcinogenesis. This evidence concerns the gene SEMA3F and non-small cell lung carcinoma.